“Identification of RUNX1 and IFNGR2 as prognostic-related biomarkers correlated with immune infiltration and subtype differentiation of low-grade glioma” (2023) Biomolecules and Biomedicine, 23(3), pp. 405–425. doi:10.17305/bjbms.2022.8086.